Compare Endeavour Silver Corp (EXK) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Endeavour Silver Corp vs GeneDx Holdings Corp — how do they compare? Endeavour Silver Corp trades at $10.63 (market cap $3.14B), while GeneDx Holdings Corp trades at $82.77 (market cap $2.44B). The key difference: Endeavour Silver Corp is the larger of the two by market cap, and Endeavour Silver Corp is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| EXK | WGS | |
|---|---|---|
Market Cap | $3.14B | $2.44B |
Sector | Basic Materials | Technology |
52-Week High | $14.12 | $167.51 |
52-Week Low | $5.31 | $34.51 |
Enterprise Value | $3.14B | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Endeavour Silver (EXK) trades at $10.60, up 3.52% today, with strong technical momentum and bullish analyst sentiment. The company shows improving fundamentals with Q1 2026 earnings beating expectations and revenue growth projected from $468M in 2025 to $737M in 2026. Recent news highlights operational expansion, including the Terronera mine ramp-up and a new $25M credit facility, supporting future growth in silver and gold production.
Outlook is positive with 78.6% analyst buy ratings and a $15.50 consensus price target offering 46% upside. Key risks include execution of mine expansions, commodity price volatility, and the company's transition to profitability after a 2025 net loss. The stock presents a growth opportunity if operational targets are met, though investors should monitor quarterly earnings consistency.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Endeavour Silver Corp
Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.
Read more on EXK →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
